The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Share News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Stocks waver as IMF cuts global growth forecast

Tue, 19th Apr 2022 17:06

(Alliance News) - Stocks in London ended lower on Tuesday, following the long Easter weekend, after the IMF warned Russia's invasion of Ukraine will weigh heavily upon global economic growth.

The new forecast now pointed to global economic growth at 3.6% for 2022. That is another drastic reduction in the outlook, primarily due to unprecedented economic pressures. Already in January, the IMF had lowered its global economic forecast for 2022 by half a percentage point, to 4.4%.

The world was already facing inflation problems, on the one side due to loose monetary policy in many wealthy nations, on the other due to supply snarls exacerbated by lingering effects of the pandemic.

Russia's invasion worsened the situation because both it and Ukraine are responsible for major commodity supplies of food and fuel. Much of what Ukraine exports is now inaccessible due to the invasion and much of what Russia sells is off limits due to sanctions set up to punish it for the attack.

The FTSE 100 index ended down 15.10 points, or 0.2%, at 7,601.28. The mid-cap FTSE 250 index lost 159.44 points, or 0.8%, at 20,962.17. The AIM All-Share index closed down 4.16 points, or 0.4%. at 1,056.00.

The Cboe UK 100 index ended down 0.1% at 757.59. The Cboe 250 closed down 0.6% at 18,457.77, and the Cboe Small Companies lost 0.5% at 15,349.55.

In mainland Europe, the CAC 40 stock index in Paris shed 0.8%, while the DAX 40 in Frankfurt ended 0.1% lower.

"European markets have got off to a lacklustre start to the week, pulling off their lows of the day, despite the IMF following the World Bank yesterday, in downgrading its outlook for the global economy," said CMC Markets analyst Michael Hewson.

In the FTSE 100, oil majors Shell and BP ended up 1.6% and 0.4% respectively, tracking spot oil prices higher.

Brent oil was quoted at USD107.80 a barrel at the London equities close, up from USD107.52 at the same time on Thursday.

At the other end of the large-caps, ITV closed down 3.6% after Berenberg downgraded the broadcaster to 'sell' from 'hold'.

In the FTSE 250, Spectris ended up 4.7% after unveiling a GBP300 million share buyback programme alongside the sale of its Omega Engineering subsidiary to Arcline Investment Management.

The precision instrumentation and controls supplier will net USD525 million from the Omega disposal. Specialist sensors provider Omega generated sales of GBP129.0 million in 2021 and adjusted earnings before interest, tax, depreciation and amortisation of GBP19.7 million.

The buyback will consist of an initial GBP150 million, "to be launched shortly", before a further GBP150 million tranche. The second instalment is subject to shareholder approval at the firm's annual general meeting on May 27.

At the bottom of the mid-caps, JTC lost 12% despite hiking its dividend after revenue and profit growth in 2021, with acquisitions helping to boost the fund manager's performance.

Revenue for 2021 grew 28% to GBP147.5 million from GBP115.1 million in 2020, and pretax profit jumped to GBP27.8 million from GBP11.2 million. Annualised new business wins totalled GBP20.9 million, up from GBP17.9 million in 2020.

The revenue growth reflected strong net organic growth of 9.6% plus inorganic growth of 19%, the firm said. JTC has been pleased with the integration and business performance of recent acquisitions, with all seven "on track", it said.

SSP closed down 6.3% after Deutsche Bank cut the food and beverage concessions operator to 'hold' from 'buy'.

Elsewhere, Sensyne Health plunged 34% after the clinical artificial intelligence company proposed delisting from London's AIM junior market.

The company is seeking approval from its shareholders for the delisting of the shares, in accordance with AIM rules, Sensyne Health explained. It will hold a general meeting on May 20.

The dollar was higher across the board in the wake of hawkish comments from St Louis Federal Reserve President James Bullard, who said a 75 basis point US interest rate hike should not be ruled out, Bloomberg reported.

Bullard, in a virtual conference held by the Council on Foreign Relations think tank, said the Fed would need to move decisively as it eyes lifting interest rates to around 3.5% this year.

Moreover, Bullard noted a hike of more than 50 basis points at a single policy meeting is not his "base case at this point", however. "I wouldn't rule it out, but it is not my base case here," he explained.

The next meeting of the policy-making Federal Open Market Committee is on May 4.

The pound was quoted at USD1.2997 at the London equities close, down from USD1.3060 at the close on Thursday.

The euro stood at USD1.0785 at the European equities close, lower against USD1.0797.

Against the yen, the dollar was trading at JPY128.77, up sharply from JPY125.91 late Thursday. The buck hit an intraday high of USD128.92 - its highest level since May 2002.

New York was higher at the London equities close weighing mixed earnings and a weakening global growth outlook against bargain-hunting tendencies following recent losses.

The DJIA was up 1.1%, the S&P 500 index up 1.3% and the Nasdaq Composite up 1.6%.

On Wall Street, Johnson & Johnson was the best Dow performer, up 4.0%. The drugmaker reported a drop in first-quarter earnings, despite sales growth of 5%.

The New Brunswick, New Jersey-based firm said earnings fell 17% to USD5.15 billion in the first three months of 2022 from USD6.20 billion a year previous. Per share, earnings dropped to USD1.93 from USD2.32, also representing a 17% fall.

Sales rose 5.0% to USD23.43 billion from USD22.32 billion. In Consumer Health, sales declined 1.5%, but in Pharmaceuticals, sales grew 6.3%.

The company hiked its quarterly dividend by 6.6% to USD1.13 per share from USD1.06.

Streaming services provider and content producer Netflix will report first-quarter earnings after the closing bell.

Gold stood at USD1,953.33 an ounce at the London equities close, lower against USD1,964.54 late Thursday.

The economic events calendar on Wednesday has Germany producer prices at 0700 BST.

The UK corporate on Wednesday has trading statements from distribution company Bunzl, gambling firm 888 Holdings and gold miner Centamin.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
14 Jan 2022 09:50

Sensyne shares drop as it seeks shareholder funds to continue trading

Sensyne shares drop as it seeks shareholder funds to continue trading

Read more
24 Dec 2021 08:47

Sensyne wins two agreements for its Sensight AI data platform

Sensyne wins two agreements for its Sensight AI data platform

Read more
24 Dec 2021 08:25

Sensyne strikes one-year agreement with Exscientia

(Sharecast News) - Clinical artificial intelligence company Sensyne Health has struck a one-year agreement with Exscientia to leverage "the deep learning AI capabilities" of its platform to study real-world health data.

Read more
3 Dec 2021 17:29

Sensyne Health enters research agreement with NHS Foundation trust

Sensyne Health enters research agreement with NHS Foundation trust

Read more
3 Dec 2021 14:42

Sensyne signs five-year patient data deal with Cambridge NHS trust

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five-year, non-exclusive strategic research agreement with Cambridge University Hospitals NHS Foundation Trust, it announced on Friday.

Read more
30 Nov 2021 19:13

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

TRADING UPDATES: Zambeef sales continue climb; Watchstone files claim

Read more
2 Nov 2021 17:11

IN BRIEF: Sensyne Health considers management buyout of company

IN BRIEF: Sensyne Health considers management buyout of company

Read more
22 Oct 2021 16:03

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
21 Oct 2021 17:55

IN BRIEF: Sensyne partner Excalibur gets European Covid test approval

IN BRIEF: Sensyne partner Excalibur gets European Covid test approval

Read more
15 Oct 2021 18:12

TRADING UPDATES: Miton Global to become MIGO; Guild makes new signings

TRADING UPDATES: Miton Global to become MIGO; Guild makes new signings

Read more
15 Oct 2021 14:44

Sensyne enters health data partnership with US-based OMNY

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced a new strategic relationship with US-based data network company OMNY Health on Friday.

Read more
1 Oct 2021 11:15

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

TRADING UPDATES: Sensyne revenue jumps; Stranger Holdings loss narrows

Read more
24 Sep 2021 16:03

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
9 Sep 2021 18:16

TRADING UPDATES: Cohort gets contract extension; IQGeo wins new deal

TRADING UPDATES: Cohort gets contract extension; IQGeo wins new deal

Read more
2 Sep 2021 21:44

TRADING UPDATES: Challenger Energy hails Saffron-2 well; SDCL placing

TRADING UPDATES: Challenger Energy hails Saffron-2 well; SDCL placing

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.